VolitionRx plunges on $20 mln stock deal

VolitionRX

10/02/2021 14:56

** VolitionRx  VNRX.A  shares down 15.3% at $5.31 after co
prices stock deal
    ** VNRX on course for biggest one-day pct fall since last
Mar
    ** Diagnostics firm sells 3.8 mln shares, raises $20 mln for
general corp purposes, including continued product development,
clinical studies, product commercialization  urn:newsml:reuters.com:*:nPn7kZgQKa
    ** Offering prices at $5.25, ~16% discount to stock's Tues
close
    ** Cantor Fitzgerald sole bookrunner
    ** VNRX has 48.2 mln shares outstanding and 30.3 mln of free
float, per Refinitiv
    ** Decline on Weds cuts stock's YTD gain to ~37% YTD

 (Lance Tupper is a Reuters market analyst. The views expressed
are his own)
 ((lance.tupper.tr.com@reuters.net
lance.tupper@tr.com 1-332-219-1430))